Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer

Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is defined by the absence of estrogen receptor and progesterone receptor and human epidermal growth factor receptor 2 (HER2) overexpression. This malignancy, representing 15–20% of breast cancers, is a clinical challenge due to the lack of targeted treatments, hi...

Full description

Bibliographic Details
Main Authors: Pere Llinàs-Arias, Sandra Íñiguez-Muñoz, Kelly McCann, Leonie Voorwerk, Javier I. J. Orozco, Miquel Ensenyat-Mendez, Borja Sesé, Maggie L. DiNome, Diego M. Marzese
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
epigenetics
TNBC
immunotherapy
cancer
breast cancer
epigenetic drugs
Online Access:https://www.mdpi.com/2072-6694/13/16/4139

Internet

https://www.mdpi.com/2072-6694/13/16/4139

Similar Items